Navigation Links
First European Patients Treated With the Percutaneous MitraClip(R) System
Date:9/23/2008

European Physicians Show Strong Interest in MitraClip System

MENLO PARK, Calif., Sept. 23 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today that the first two patients have been treated with its MitraClip(R) system in Hamburg, Germany. The MitraClip system is the first commercially available device which enables a non-surgical option for patients suffering from the effects of mitral regurgitation (MR).

MR is the second most common type of heart valve insufficiency in Europe, and the most common in the United States, affecting millions of people worldwide. Both in Europe and the United States, the vast majority of patients are untreated, which leaves their hearts affected by the chronic volume overload caused by MR, requiring the heart to work harder, and ultimately leading to heart failure.

The first European patients were treated by the team led by Olaf Franzen, M.D., Dietmar Koschyk, M.D., Hendrik Treede, M.D., and Professor Joachim Schofer, M.D. at the University Heart Center in Hamburg, Germany.

"The immediate results after implanting the MitraClip device have surpassed our initial expectations," said Dr. Franzen, interventionalist for adult structural and congenital heart disease at the University Heart Center.

"The patients we treated last week have heart failure and were considered to be high risk surgical patients," said Professor and Chairman Thomas Meinertz M.D., Ph.D. at the University Heart Center. "Now with the availability of the MitraClip system, we are able to treat these patients with a much less invasive percutaneous alternative for mitral repair."

"This new therapy may be an excellent alternative for this group of patients with heart failure," said Professor Herrmann Reichenspurner, M.D., Ph.D, Head of Cardiac Surgery and Medical Director at the University Heart Center. "As a cardiac surgeon, there are times when
'/>"/>

SOURCE Evalve, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
2. Trius Doses First Patient in Antibacterial Phase 2 Trial
3. First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
4. Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
5. MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
8. The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC
9. CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial
10. FDA Approves First Hepatitis B Viral Load Test
11. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...URHAM, N.C., Dec. 3 In ...thcare information technologies in the evolving he...d the Duke Center for Health Informatics (DCHI) to...HI will oversee an innovative interdisciplinary ap...tion of physicians, nurses and healthcare administ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Alzheimer,s dise...s a person can receive. This irreversible, progres...king skills and eventually even the ability to car...f dementia among older people, AD affects as many ... to the National Institute on Aging. ,, (Logo:...
(Date:12/3/2009)...LAMAZOO, Mich., Dec. 3 S...that its Board of Directors has authorized the Com...n stock. The manner, timing and amount of any pur...ent based on their evaluation of market conditions...t to regulatory considerations. Purchases may be ...
Breaking Medicine Technology:Duke Medicine to Train Healthcare Professionals in Health Informatics 2Duke Medicine to Train Healthcare Professionals in Health Informatics 3Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Women More Likely Than Men to Reject Unattractive Babies 49890 1Women More Likely Than Men to Reject Unattractive Babies 49890 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 1Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 2Maui Jim Teams With Unite for Sight in New Buy One Give One Program to Improve Eye Health Amongst the Worlds Most Needy 49888 3TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility 49886 1TrinityCare Senior Living Announces Funding Agreement for Fourth Senior Living Facility 49886 2
...nalyses of secondary endpoints of a long-term safe..., Nasdaq: SHPGY, TSX: SHQ) ulcerative colitis,(UC)... on LIALDA in,patients with mild to moderate ulcer...l, a long-term, Phase III, open-label 12-14 month,...The American College of,Gastroenterology (ACG) mee...
...alized,patients with schizophrenia showed signific...) (paliperidone) Extended-Release Tablets as compa...mptom improvement was,observed with INVEGA as earl...the end of the two-week study period, according to...al U.S. Psychiatric and Mental Health,Congress in ...
Other Medicine Technology:New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 2New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 3New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 4New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 5New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 6New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG 7INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 2INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 3INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 4INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 5INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 6INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients 7
(Date:12/4/2009)... Plantar fasciitis heel pain af... each year, and cold therapy has been cited by the...ective treatment option. In response to these fin... of compressive cold therapy systems for plantar f...combination night splint therapies. , ...
(Date:12/3/2009)... Chiropractic Traffic has gotte...away a very popular marketing tool. $1 gets chirop...teriods. Chiropractic Traffic is even including c... (PRWEB) December 3, 2009 ...d new Email marketing tool. Chiropractic Marketin...
(Date:12/3/2009)... , MINNEAPOLIS, Dec. 3 Childre...med a recipient of the 2009 Leapfrog Top Hospitals...or delivering care that is among the best in the n...fficiency. ,, The Leapfrog survey is the only n...ues including mortality rates for common procedure...
(Date:12/3/2009)..., WASHINGTON, Dec. 3 ...r the Aging (AAHSA) commends the Senate for passin... reassures seniors by protecting guaranteed benefi...thin the program. ,, "With the silver tsunami o...ortant for health care reform legislation currentl...
(Date:12/3/2009)...of aggressor, victim often play out at school and ...HealthDay News) -- School bullies are also likely ...ding to an Italian study that included 195 childre...ants -- all with a sibling no more than four years...they bullied or were bullied at school or at home....
Breaking Medicine News(10 mins):Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:New Chiropractic Marketing: A $1 Chiropractic Marketing Tool that Can Make Users $1000s 2Health News:Children's Hospitals and Clinics of Minnesota Receives National Recognition for Quality and Efficiency 2Health News:Bullies May Intimidate Siblings, Too 2
...reast cancer trials has confirmed that a combinati...b chemotherapy improves survival in women with op...Dahabreh from the University of Athens conducted t...es. All the trials compared disease-free s...
...er treatments using their knowledge about an obesi... to kill cancer cells in the laboratory . ...in tumour cells and blocks the protein's function ...School of Medicine. As part of the study, ...
...ecular Biology Laboratory (EMBL) and the Universit...ect humans from nephronopthisis (NPHP), a serious ...auses kidney degeneration during childhood and kid... mutations in the gene GLIS2 can lead to nephronop...
...attering in the western media, the government of t...iaoyu , a former head of the countrys Food and Dru...f taking 6.5m yuan ($850,000; 425,400) in bribes a...China has been criticised over a number of recent ...
... supplying 150,000 HIV sufferers with free anti-re... national AIDS commission (NAC) said on Monday . ... we hope to hit 150,000 by the end of December whe...tch of funding from the global fund against AIDS, ...
...d at the annual meeting of the American Society of...007), scientists implemented a successful bioeradi...s Lake Victoria. Two insect biocontrol speci...aterways in the southern United States. Th...
Other Medicine News:Health News:Boffins Identify Gene That can Protect Humans from Nephronopthisis 2Health News:Food Safety Chief Executed for Bribery in China 2Health News:Food Safety Chief Executed for Bribery in China 3Health News:Food Safety Chief Executed for Bribery in China 4Health News:Water Hyacinth is Used for Health Improvements in Africa 2Health News:Water Hyacinth is Used for Health Improvements in Africa 3Health News:Water Hyacinth is Used for Health Improvements in Africa 4
...e analyzer that ensures accurate results, test aft...ing "hands on" operator time. And its convenient, ...s large or small., ,The Chemstrip Criterion I...ssing of Chemstrip 10 MD Urine Test Strips from Ro...
Integra Epilepsy Epidural Peg Electrodes and Accessories
Integra Epilepsy Strip Electrodes
...n R. Gates and Mary E. Dunn at the Minnesota Epile...reliability, safety and ease of use. For cortical ...ounted flush with the electrode surface, are indiv...and depth electrodes are fitted with a gold plated...
Medicine Products: